公司上市以来历次分配方案一览 | 日期 | 分配方案 | 派现金额合计（亿元） | 股息率（%） | | --- | --- | --- | --- | | 2025.06.30 | 10派3.5元（含税） | 6.14 | 0.92 | | 2024.12.31 | 10派5.8元（含税） | 10.17 | 1.78 | | 2024.06.30 | 10派3.5元（含税） | 6.14 | 1.08 | | 2023.12.31 | 10派5.8元（含税） | 10.18 | 1.35 | | 2022.12.31 | 10派2.9元（含税） | 5.09 | 0.72 | | 2021.12.31 | 10派2.9元（含税） | 5.07 | 0.74 | | 2020.12.31 | 10派2.3元（含税） | 4.02 | 0.92 | | 2019.12.31 | 10派2.8元（含税） | 4.90 | 0.97 | | 2018.12.31 | 10转增2派3.3元（含税） | 4.81 | 0.70 | | 2017.12.31 | 10转增5派7.2元（含税） | 7.00 | 1.25 ...

公司上市以来历次分配方案一览 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） 资金面上看，该股今日主力资金净流出243.59万元，近5日主力资金净流入4078.61万元。 两融数据显示，该股最新融资余额为3.74亿元，近5日增加2327.96万元，增幅为6.65%。 按申万行业统计，华邦健康所属的医药生物行业共有15家公司公布了2025半年度分配方案，派现金额最 多的是药明康德，派现金额为10.03亿元，其次是华润三九、白云山，派现金额分别为7.51亿元、6.50亿 元。（数据宝） 2025半年度医药生物行业分红排名 | 代码 | 简称 | 每10股送转 | 每10股派现 | 派现金额（万 | 派现占净利润比例 | 股息率 | | --- | --- | --- | --- | --- | --- | --- | | | | （股） | （元） | 元） | （%） | （%） | | 603259 | 药明康 德 | 0.00 | 3.5 | 100308.38 | 11.72 | 0.58 | | 000999 | 华润三 九 | 0.00 | 4.5 | 7513 ...

Market Overview - A-share market showed mixed performance with the Shanghai Composite Index closing at 3727.29 points, down 0.02%, and the Shenzhen Component Index at 11821.63 points, down 0.12% [2] - Total trading volume in the A-share market was 26,412.63 billion, a decrease of 1,683.64 billion compared to the previous trading day [2] Capital Flow - Main capital outflow from the A-share market reached 450.86 billion, with an opening net outflow of 177.48 billion and a closing net outflow of 37.84 billion [3][4] - The CSI 300 index experienced a net outflow of 99.23 billion, while the ChiNext saw a net outflow of 231.66 billion, and the STAR Market had a net inflow of 5.22 billion [5][6] Sector Performance - The food and beverage sector led with a net inflow of 28.49 billion, showing a rise of 1.60% [7][8] - Other sectors with net inflows included real estate (18.33 billion) and retail (12.91 billion), while the electronics sector faced the largest outflow at -179.36 billion [8] Institutional Activity - Zhongyou Capital had the highest net inflow among individual stocks with 10.47 billion [9] - Institutions showed interest in several stocks, with notable net purchases in Electronic City and Huasheng Tiancai, while stocks like Yingshi Innovation saw significant net selling [11][12] Institutional Focus - Institutions are currently focusing on stocks such as Dahua Technology, Anfu Technology, and Pengding Holdings, with target price increases ranging from 22.60% to 56.92% [13]

Market Overview - The A-share market showed a mixed performance with the Shanghai Composite Index closing at 3727.29 points, down 0.02%, the Shenzhen Component at 11821.63 points, down 0.12%, and the ChiNext Index at 2601.74 points, down 0.17%. The North Star 50 Index increased by 1.27% [1] - Total trading volume in the A-share market was 26,412.63 billion yuan, a decrease of 1,683.64 billion yuan compared to the previous trading day [1] Capital Flow - The main capital in the A-share market experienced a net outflow of 450.86 billion yuan, with an opening net outflow of 177.48 billion yuan and a closing net outflow of 37.84 billion yuan [2] - The CSI 300 index saw a net outflow of 99.23 billion yuan, while the ChiNext experienced a net outflow of 231.66 billion yuan, and the Sci-Tech Innovation Board had a net inflow of 5.22 billion yuan [4] Sector Performance - In the food and beverage sector, there was a net inflow of 28.49 billion yuan, leading among the sectors [6] - Other sectors with net inflows included real estate with 18.33 billion yuan and retail with 12.91 billion yuan. The electronic sector faced the largest net outflow of 179.36 billion yuan [7] Institutional Activity - Zhongyou Capital had the highest net inflow of 10.47 billion yuan among individual stocks [8] - The institutional buying activity was noted in stocks like Dianzicheng and Huasheng Tianc, while stocks like Yingshi Chuangxin saw significant net selling [10] Institutional Focus - Recent institutional ratings highlighted stocks such as Dahua Technology with a target price of 28.56 yuan, representing a potential upside of 56.92%, and Anfu Technology with a target price of 45.00 yuan, indicating a 24.86% upside [12]

Group 1 - The report constructs a valuation scoring system to assess the price-performance ratio of convertible bond underlying stocks, focusing on quickly and accurately evaluating individual stock valuation levels while controlling for drawdown risks [1][9] - The valuation framework employs both vertical (relative to historical levels) and horizontal (relative to peers) analyses to position stocks in a two-dimensional space, allowing for a comprehensive assessment of their valuation [1][9] - The horizontal analysis identifies which underlying stocks have better valuation cost-effectiveness compared to others, using a set of primary and secondary indicators to filter out unsuitable metrics [1][10][11] Group 2 - The horizontal valuation framework aims to determine which convertible bonds (or underlying stocks) are relatively inexpensive at a given moment, addressing the challenge of cross-industry valuation comparisons [10][11] - The report identifies suitable primary indicators for various industries, categorizing them based on the adequacy of data points, stability across periods, and the dispersion of individual stock valuations [11][12][16] - The report highlights that the PE (3-year non-negative average) and PB indicators are widely applicable across industries, with the introduction of PE (3-year non-negative average) providing a more reliable alternative to traditional PE metrics [17][18] Group 3 - The vertical analysis framework assesses which underlying stocks have improved valuation cost-effectiveness compared to their historical levels, using data from June 2021 to the present [28][29] - The report finds that stocks with low vertical valuations tend to exhibit greater upward elasticity in bullish markets, with those above the 80% valuation threshold showing significantly lower average price increases [29][30] - The report identifies low-valued convertible bond targets worth attention, particularly in industries such as defense, basic chemicals, and construction decoration, which have shown high elasticity in the current market environment [34][36]

A股总市值首次突破100万亿元大关，百元股阵营迎来强势扩张。 截至8月18日收盘，A股中的百元股数量，已经激增至134只，较年初的69只近乎翻倍。其中，寒武纪-U（688256.SH） 年内大涨超过40%，19日盘中一度突破千元关口，收盘虽然回落至933元/股，但也成为贵州茅台（600519.SH）之后， 最有希望跻身"千元股俱乐部"的标的。 这些A股"豪门"中，哪些行业的百元股涨势最为突出？现有百元股的估值，相较历史高点处于何种水平？且看第一财 经细细梳理。 百元股数量超较年初翻倍 市场普遍将百元股（股价超过100元的个股）的数量，视为衡量市场热度的重要风向标，这类个股因其高股价特性往 往吸引投资者重点关注。 今年以来，A股百元股阵营呈现明显扩张态势。截至8月18日，百元股数量已从年初的69只激增至134只，几乎翻倍。 这一过程中，百元股数量随市场波动而变化明显。2月末，百元股的数量为90只，4月因市场大跌一度缩减至67只，随 后逐步回升至7月末的130余只，到8月18日已突破134只。 百元股的"前三甲"，分别为贵州茅台、寒武纪-U、同花顺（300033.SZ），股价分别为1428.50元/股、950元/ ...

Core Viewpoint - The average stock price of the STAR Market is 36.42 yuan, with 53 stocks priced over 100 yuan, indicating a mixed performance in the market with 221 stocks rising and 360 stocks falling today [1]. Group 1: Stock Performance - The highest closing price on the STAR Market is 933.98 yuan for Cambrian, which fell by 1.69% today [1]. - Among the stocks priced over 100 yuan, the average decline today was 0.51%, with 14 stocks rising and 39 stocks falling [1]. - The stocks with the highest premium relative to their issue price include Cambrian (1350.50%), Baoli Tianheng (1167.21%), and Rejing Bio (1143.70%) [1]. Group 2: Industry Concentration - The stocks priced over 100 yuan are concentrated in the electronics, pharmaceutical, and computer industries, with 23, 11, and 8 stocks respectively [1]. Group 3: Capital Flow - The net outflow of main funds from stocks priced over 100 yuan today was 1.968 billion yuan, with the highest net inflows seen in Xinyuan Technology (27.98 million yuan), Juguang Technology (10.04 million yuan), and Rejing Bio (8.22 million yuan) [2]. - The total margin balance for stocks priced over 100 yuan is 41.903 billion yuan, with Cambrian, Haiguang Information, and Zhongwei Company having the highest margin balances of 6.260 billion yuan, 5.302 billion yuan, and 2.969 billion yuan respectively [2].

福瑞股份8月19日交易公开信息 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 深股通专用 | 9183.53 | 2337.46 | | 买二 | 华泰证券股份有限公司上海武定路证券营业部 | 7344.78 | 20.59 | | 买三 | 国泰海通证券股份有限公司上海松江区中山东路证券营 业部 | 7335.45 | 0.70 | | 买四 | 东方财富证券股份有限公司河南分公司 | 2467.45 | 0.00 | | 买五 | 中信建投证券股份有限公司长沙芙蓉中路证券营业部 | 2166.89 | 3.61 | | 卖一 | 诚通证券股份有限公司上海天山路证券营业部 | 0.00 | 4200.54 | | 卖二 | 国泰海通证券股份有限公司上海杨浦区四平路证券营业 | 0.00 | 4038.58 | | | 部 | | | | 卖三 | 国泰海通证券股份有限公司重庆解放碑证券营业部 | 119.19 | 3962.43 | | 卖四 | 国泰海通证券股份有限公司昆明人民中路 ...

中国经济网北京8月19日讯 药明康德（603259）(603259.SH)今日股价收报90.26元，跌幅6.93%。 7月30日，药明康德股价在盘中达到了年内最高点102.49元。 而7月29日至7月31日，共有17家券商发布研报唱多药明康德，分别为：中国国际金融股份有限公司、华 泰证券股份有限公司、信达证券（601059）股份有限公司、湘财证券股份有限公司、招商证券股份有限 公司、光大证券股份有限公司、西部证券（002673）股份有限公司、国泰海通证券股份有限公司、浦银 国际证券有限公司、华西证券（002926）股份有限公司、中信建投（601066）证券股份有限公司、国投 证券股份有限公司、国信证券股份有限公司、中国银河（601881）证券股份有限公司、西南证券股份有 限公司、开源证券股份有限公司、中泰证券（600918）股份有限公司。 ...

Core Viewpoint - The number of stocks priced over 100 yuan in A-shares has surged to 134, nearly doubling from 69 at the beginning of the year, indicating a strong market expansion and investor interest in high-priced stocks [2][5]. Group 1: Market Expansion - As of August 18, the number of hundred-yuan stocks has increased significantly, with fluctuations observed throughout the year, peaking at 134 stocks [2][3]. - The top three hundred-yuan stocks are Kweichow Moutai, Cambrian, and Tonghuashun, with prices of 1428.50 yuan, 950 yuan, and 404.9 yuan respectively [2][3]. Group 2: Performance of New Hundred-Yuan Stocks - Among the 134 hundred-yuan stocks, 71 are newly listed stocks that entered the hundred-yuan club this year, with many from the electronics and power equipment sectors [3][5]. - Notable performers include Shenghong Technology, which rose from 41.88 yuan to 231.77 yuan, marking a 450% increase, and Guangshengtang, which increased from 31.25 yuan to 172 yuan, achieving a 450% rise [3][5]. Group 3: Industry Characteristics - The majority of new hundred-yuan stocks are concentrated in technology-driven sectors such as power equipment, electronics, pharmaceuticals, and defense [5][6]. - Stocks like Yingstone Innovation and Haibo Sunchron have shown remarkable growth, with increases of 469.71% and 462.38% respectively [4][5]. Group 4: Valuation Trends - Many hundred-yuan stocks are approaching historical high valuations, with 81 stocks having total market values in the top 90th percentile historically [7][8]. - A significant number of stocks, including Tonghuashun and Guangshengtang, are nearing or have reached their historical maximum market values [8][9]. Group 5: Earnings Performance - Earnings performance among high-priced stocks is polarized, with some companies like Borui Pharmaceutical showing significant declines in revenue and profit, while others like Cambrian and Xinyisheng report explosive growth in earnings [10]. - Cambrian's revenue for Q1 2025 reached 1.111 billion yuan, a 4230.22% increase year-on-year, marking its first quarterly profit since listing [10].